Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.35
Delayed Data
As of Sep 02
 +1.15 / +2.12%
Today’s Change
41.72
Today|||52-Week Range
60.34
+30.79%
Year-to-Date

Today’s Trading

Previous close54.20
Today’s open54.91
Day’s range54.44 - 55.37
Volume771,178
Average volume (3 months)1,328,700
Market cap$108.7B
Dividend yield1.37%
Data as of 4:02pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+5.60%
P/E ratio4.6
Price/Sales7.07
Price/Book21.47

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+5.40+1.84%
ABBVAbbVie+0.48+0.79%
BMYBristol-Myers Squibb+1.41+2.42%
GSKGlaxoSmithKline+1.17+2.96%
Data as of 4:03pm ET, 09/02/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$0.46
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

Partner Offers